Medical devices including blood and plasma derivates

The committee adopted the recommendation for second reading (under the codecision procedure) by Antonios TRAKATELLIS (EPP-ED, GR) approving the common position of the Council on amending directive 93/42/EEC as regards medical devices incorporating stable derivatives of human blood or human plasma. The common position had incorporated all the relevant amendments adopted by Parliament at first reading and the committee therefore felt that the directive should be adopted without delay. It nevertheless specifically urged the Commission and Council to declare that they would proceed very rapidly to draw up a proposal for a directive covering the establishment of rules on non-viable tissues or substances of human origin, derived from those tissues, so as to complete legislation in this very important sector.�